• Geographically MMDS covers most of the MENA markets with a deep focus on key countries in the gulf, Levant and North Africa. We continuously look forward to consolidate our presence in some of the region’s emerging markets like Sudan and Libya.
  • MENA region is characterized with a steadily growing pharmaceutical business which witnessed considerable growth over the last years backed by favorable demographic and economic factors.
  • The projected CAGR for the region is very attractive compared to mature markets or other emerging markets, MENA pharmaceutical markets had reached 63 Billions USD in 2016, knowing that local manufacturing production is fragmented and geared towards branded generics, but dependence on imports remains.
  • MMDS is eager to strengthen the presence in MENA markets in the mid and long term to benefit from the tremendous opportunities in different markets of the region.